- Home
- BANL vs CALC Comparison
BANL vs CALC Comparison
Compare BANL & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- CALC
- Stock Information
- Founded
- BANL 2015
- CALC 2011
- Country
- BANL Malaysia
- CALC United States
- Employees
- BANL N/A
- CALC N/A
- Industry
- BANL Oil Refining/Marketing
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- BANL Energy
- CALC Health Care
- Exchange
- BANL Nasdaq
- CALC Nasdaq
- Market Cap
- BANL 31.5M
- CALC 25.2M
- IPO Year
- BANL 2023
- CALC N/A
- Fundamental
- Price
- BANL $1.12
- CALC $1.46
- Analyst Decision
- BANL
- CALC Strong Buy
- Analyst Count
- BANL 0
- CALC 3
- Target Price
- BANL N/A
- CALC $16.33
- AVG Volume (30 Days)
- BANL 45.7K
- CALC 63.7K
- Earning Date
- BANL 04-16-2025
- CALC 05-12-2025
- Dividend Yield
- BANL N/A
- CALC N/A
- EPS Growth
- BANL N/A
- CALC N/A
- EPS
- BANL N/A
- CALC N/A
- Revenue
- BANL $521,173,543.00
- CALC N/A
- Revenue This Year
- BANL N/A
- CALC N/A
- Revenue Next Year
- BANL N/A
- CALC N/A
- P/E Ratio
- BANL N/A
- CALC N/A
- Revenue Growth
- BANL 24.34
- CALC N/A
- 52 Week Low
- BANL $0.55
- CALC $1.45
- 52 Week High
- BANL $1.35
- CALC $6.27
- Technical
- Relative Strength Index (RSI)
- BANL 57.16
- CALC 26.67
- Support Level
- BANL $0.80
- CALC $1.57
- Resistance Level
- BANL $1.17
- CALC $1.88
- Average True Range (ATR)
- BANL 0.10
- CALC 0.17
- MACD
- BANL 0.01
- CALC -0.02
- Stochastic Oscillator
- BANL 86.04
- CALC 1.72
About BANL CBL International Limited
CBL International Ltd is a company that provides a complete range of marine fuel logistics services. It sources the highest quality marine fuel from its trusted suppliers and ensures timely delivery to its customers. The company's expertise lies in providing a seamless and efficient one-stop solution for vessel refueling needs, making it a reliable partner for shipping companies. CBL International Ltd has a strong presence in China, Hong Kong, and Malaysia.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.